RS BioTherapeutics Creates Therapeutic Expert Council to Provide Guidance on Development of First-in-Class Agent Focused on Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis RS BioTherapeutics is pleased to announce the formation of its Therapeutic Expert Council (TEC).

Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023 Golden, Colorado, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein...